David Colquhoun

Summary

Affiliation: University of Queensland
Country: Australia

Publications

  1. ncbi request reprint Nutraceuticals: vitamins and other nutrients in coronary heart disease
    D M Colquhoun
    Wesley and Greenslopes Private Hospitals, Brisbane, Australia
    Curr Opin Lipidol 12:639-46. 2001
  2. ncbi request reprint Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    David M Colquhoun
    University of Queensland
    Aust Fam Physician 31:25-6, 29-30. 2002
  3. ncbi request reprint Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
    David Colquhoun
    Wesley Medical Centre, University of Queensland, 40 Chasely Street, Auchenflower, Qld 4066, Australia
    Eur Heart J 25:771-7. 2004
  4. ncbi request reprint "Stress" and coronary heart disease: psychosocial risk factors
    Stephen J Bunker
    National Heart Foundation, 411 King Street, West Melbourne, VIC 3003, Australia
    Med J Aust 178:272-6. 2003
  5. ncbi request reprint White blood cell count predicts reduction in coronary heart disease mortality with pravastatin
    Ralph A H Stewart
    Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
    Circulation 111:1756-62. 2005
  6. ncbi request reprint Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial
    Paul J Nestel
    Baker Heart Research Institute, Melbourne, Australia
    Am J Clin Nutr 81:1322-9. 2005

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Nutraceuticals: vitamins and other nutrients in coronary heart disease
    D M Colquhoun
    Wesley and Greenslopes Private Hospitals, Brisbane, Australia
    Curr Opin Lipidol 12:639-46. 2001
    ..Marine lipid supplementation needs to be considered in all patients who have manifest coronary heart disease. For most supplements more data are needed before confident recommendations can be made...
  2. ncbi request reprint Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    David M Colquhoun
    University of Queensland
    Aust Fam Physician 31:25-6, 29-30. 2002
    ..Ninety percent of patients survive the acute episode and remain at high risk of further coronary events...
  3. ncbi request reprint Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
    David Colquhoun
    Wesley Medical Centre, University of Queensland, 40 Chasely Street, Auchenflower, Qld 4066, Australia
    Eur Heart J 25:771-7. 2004
    ....
  4. ncbi request reprint "Stress" and coronary heart disease: psychosocial risk factors
    Stephen J Bunker
    National Heart Foundation, 411 King Street, West Melbourne, VIC 3003, Australia
    Med J Aust 178:272-6. 2003
    ..The identified psychosocial risk factors should be taken into account during individual CHD risk assessment and management, and have implications for public health policy and research...
  5. ncbi request reprint White blood cell count predicts reduction in coronary heart disease mortality with pravastatin
    Ralph A H Stewart
    Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
    Circulation 111:1756-62. 2005
    ....
  6. ncbi request reprint Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial
    Paul J Nestel
    Baker Heart Research Institute, Melbourne, Australia
    Am J Clin Nutr 81:1322-9. 2005
    ..Patients in Australia and New Zealand (n = 9014) who participated in a large secondary prevention trial had significantly different CHD mortality rates...